IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PRESTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.743
EU - Europa 10.944
AS - Asia 6.998
SA - Sud America 738
AF - Africa 90
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 20
Totale 38.561
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.614
PL - Polonia 3.897
CN - Cina 2.989
UA - Ucraina 2.072
SG - Singapore 1.736
DE - Germania 1.355
HK - Hong Kong 1.175
IT - Italia 1.046
BR - Brasile 650
FI - Finlandia 640
GB - Regno Unito 495
RU - Federazione Russa 396
IE - Irlanda 368
TR - Turchia 355
IN - India 233
FR - Francia 207
VN - Vietnam 199
CZ - Repubblica Ceca 101
SE - Svezia 85
CA - Canada 72
ES - Italia 62
ID - Indonesia 62
NL - Olanda 48
BE - Belgio 41
IR - Iran 37
AT - Austria 36
BD - Bangladesh 29
ZA - Sudafrica 26
AU - Australia 22
MA - Marocco 22
JP - Giappone 21
MX - Messico 21
AR - Argentina 20
EU - Europa 19
EC - Ecuador 18
MU - Mauritius 18
PK - Pakistan 15
CH - Svizzera 14
IQ - Iraq 14
AZ - Azerbaigian 13
CO - Colombia 13
PH - Filippine 13
IL - Israele 11
KR - Corea 11
PE - Perù 11
CL - Cile 10
JM - Giamaica 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
PA - Panama 9
RO - Romania 9
KG - Kirghizistan 8
LT - Lituania 8
LV - Lettonia 8
VE - Venezuela 8
CU - Cuba 7
LK - Sri Lanka 7
TH - Thailandia 7
TW - Taiwan 7
UZ - Uzbekistan 7
DK - Danimarca 6
EG - Egitto 6
GE - Georgia 6
GR - Grecia 6
KE - Kenya 6
KZ - Kazakistan 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
SK - Slovacchia (Repubblica Slovacca) 6
LB - Libano 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
DZ - Algeria 4
HR - Croazia 4
NO - Norvegia 4
PY - Paraguay 4
EE - Estonia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
IS - Islanda 2
JO - Giordania 2
LU - Lussemburgo 2
MD - Moldavia 2
MY - Malesia 2
SN - Senegal 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CR - Costa Rica 1
ET - Etiopia 1
NI - Nicaragua 1
Totale 38.556
Salva come PNG Salva come JPEG
Città #
Warsaw 3.893
Fairfield 3.026
Woodbridge 2.187
Jacksonville 1.579
Ashburn 1.494
Houston 1.481
Ann Arbor 1.179
Cambridge 1.173
Singapore 1.170
Hong Kong 1.163
Seattle 1.081
Wilmington 1.059
Chandler 797
Beijing 728
Princeton 669
Nanjing 579
Brescia 380
Dublin 364
Dearborn 336
New York 318
Helsinki 307
Istanbul 297
Dong Ket 181
Nanchang 180
Moscow 160
Des Moines 149
Shenyang 147
Hebei 144
Jinan 142
The Dalles 142
San Diego 130
Changsha 128
Los Angeles 126
Munich 123
Shanghai 121
Milan 110
Jiaxing 101
Lancaster 100
Tianjin 93
Boardman 77
London 76
Kunming 73
San Francisco 67
Brno 64
San Mateo 61
Hangzhou 60
Jakarta 59
São Paulo 56
Madrid 54
Turku 53
Haikou 48
Verona 48
Ningbo 43
Rome 43
Augusta 41
Lanzhou 39
Phoenix 39
Zhengzhou 38
Brussels 35
Kocaeli 35
Leawood 33
Nuremberg 33
Toronto 33
Washington 32
Guangzhou 31
Santa Clara 31
Taizhou 28
Fuzhou 26
Olomouc 26
Kilburn 25
Ardabil 24
Norwalk 24
Changchun 23
Monmouth Junction 23
Brooklyn 22
Hefei 21
Chicago 20
Taiyuan 19
Redwood City 18
Tokyo 17
Belo Horizonte 16
Rio de Janeiro 16
Vienna 16
Amsterdam 15
Nürnberg 14
Orange 14
Pune 14
Baku 13
Boston 13
Falkenstein 13
Padova 13
Frankfurt am Main 12
Stockholm 12
Brasília 11
Campinas 11
Napoli 11
Porto Alegre 11
Gunzenhausen 10
Newark 10
Ottawa 10
Totale 29.410
Salva come PNG Salva come JPEG
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 299
Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease 285
The nanostructured secretome 276
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 262
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 259
Long Pentraxin-3 inhibits FGF-dependent angiogenesis andgrowth of steroid hormone-regulated tumors 257
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 252
The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors. 252
Claudin3 is localized outside the tight junctions in human carcinomas 248
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 245
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 245
A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers 245
Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer 245
Ruolo dell’eparina e dei proteoglicani eparan solfati nella modulazione dell’angiogenesi indotta dal fattore di crescita basico dei fibroblasti 244
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 242
Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors 240
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 238
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 238
Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy. 237
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 236
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR 234
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 229
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 227
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 226
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures. 226
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 224
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 220
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 218
Mammalian tumor xenografts induce neovascularization in zebrafish embryos. 217
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 217
Angiogenic growth factors interactome and drug discovery: The contribution of surface plasmon resonance 215
Role of the soluble pattern recognition receptor PTX3 in vascular biology. 215
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 212
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 211
The pattern recognition receptor PTX3 as an angiostatic epithelial/stromal FGF-targeting inhibitor in hormonal cancers 208
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies. 202
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 180
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 178
Zebrafish disease models in hematology: Highlights on biological and translational impact 178
Long Pentraxin 3/TSG-6 Interaction: A Biological Rheostat for Fibroblast Growth Factor 2–Mediated Angiogenesis 177
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 177
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 176
Long pentraxin-3 follows and modulates bladder cancer progression 173
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist. 170
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 169
The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis. 169
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 168
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 167
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 166
The zebrafish/tumor xenograft angiogenesis assay. 165
Fibroblast growth factor-2 antagonist and Antiangiogenic activity of long-pentraxin 3-derived synthetic peptides 164
Anti-angiogenic activity of the purine analog 6-thioguanine. 162
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 161
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells. 158
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 157
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305. 155
Long Pentraxin-3 As An Epithelial-Stromal Fibroblast Growth Factor-Targeting Inhibitor In Prostate Cancer. 155
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 154
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. 153
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 152
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 151
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 149
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 149
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 148
Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. 147
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 147
Antiangiogenic effectiveness of the urokinase receptor- derived peptide UPARANT in a model of oxygen-induced retinopathy 145
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 143
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 143
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 142
Molecular cloning and knockdown of galactocerebrosidase in zebrafish: New insights into the pathogenesis of Krabbe's disease. 141
Stromal delivery of long Pentraxin-3 impairs FGF/FGFR-dependent tumor growth and metastasis 141
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 140
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 139
Heparin octasaccharides inhibit angiogenesis in vivo. 139
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver. 138
Long Pentraxin 3-Mediated Fibroblast Growth Factor Trapping Impairs Fibrosarcoma Growth 138
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 137
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 137
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 137
N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors 137
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 137
Total reflection X-Ray fluorescence spectroscopy to study Pb and Zn accumulation in zebrafish embryos 136
Dendritic cells in inflammatory angiogenesis and lymphangiogenesis 136
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case 135
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 135
Subcellular localization and biological activity of a Mr 18,000 basic fibroblast growth factor: site directed mutagenesis of a putative nuclear translocation sequence 134
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 134
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish. 133
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 132
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 132
Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases 132
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 131
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 130
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene. 128
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 128
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells. 128
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 127
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 127
Long pentraxin-3 modulates the angiogenic activity of fibroblast growth factor-2 127
Totale 18.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 181.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 181.073
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020539 0 0 0 0 0 0 0 0 0 0 0 539
2020/20216.021 181 641 232 709 324 618 262 687 758 527 702 380
2021/20223.039 176 664 62 78 41 137 191 182 150 430 232 696
2022/20232.386 417 113 114 138 178 627 17 188 315 37 112 130
2023/20242.949 186 98 337 117 124 466 123 127 680 127 58 506
2024/20255.904 86 57 40 861 652 574 516 250 708 468 1.139 553
Totale 39.303